Cagrilintide (Choose Option)

Cagrilintide — Appetite Control & Weight Management Peptide

Cagrilintide is a long-acting amylin analog designed to support significant weight reduction by helping control appetite, regulate meal frequency, and improve satiety. Often studied alongside GLP-1 agonists, it targets complementary pathways involved in hunger signaling and energy balance.

What It Supports

• Reduced appetite and lower daily food intake
• Enhanced satiety after meals
• Improved adherence to caloric deficit
• Support for long-term weight management goals

How It Works
Cagrilintide mimics the natural hormone amylin — a key regulator of gastric emptying and hunger signaling. By slowing digestion and promoting a stronger “fullness” response, it helps reinforce positive nutritional habits and reduced overeating.

Why Research It
Cagrilintide has shown promising synergy when evaluated alongside GLP-1–based compounds, suggesting potential for enhanced weight loss outcomes versus single-pathway approaches alone.

Suggested Use
Typically evaluated in once-weekly administration due to its long half-life. Dosing protocols vary by research design and objective.

For Research Use Only
Not approved by the FDA for medical use. Not intended to diagnose, treat, cure, or prevent any disease. For laboratory research and educational purposes only.